URIGEN PHARMACEUTICALS INC has a total of 22 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and environmental technology are ADVANCED SCIENT DEVELOPEMENTS, VAKCINA KFT and AZRIA MOISE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 2 | |
#6 | Japan | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Brazil | 1 | |
#9 | Mexico | 1 | |
#10 | United States | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Parsons C Lowell | 12 |
#2 | Meenan Christopher | 5 |
#3 | Vickery Dan | 5 |
#4 | Meier Andreas | 5 |
#5 | Parsons Lowell C | 5 |
#6 | Meenan Christopher P | 5 |
#7 | Goldberg Michael | 5 |
#8 | C Lowell Parsons | 4 |
#9 | Flashner Michael | 1 |
#10 | Garner William J | 1 |
Publication | Filing date | Title |
---|---|---|
CA3061891A1 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | |
MX2015009696A | Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer. | |
WO2008103442A1 | Urethral suppositories for overactive bladder | |
CA2637141A1 | Kits and improved compositions for treating lower urinary tract disorders |